Skip to content
MS
Single-pathway Pathway metabolite unreviewed

Globotriaosylceramide

0
Pathways
0
Categories
0
As substrate
0
As product

Reactions involving Globotriaosylceramide

Every recorded step where this molecule takes part

Showing all 1 reactions.

Recent literature

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease.

    Guo W, Bi J, Ji P, Xie Y. · 2026-08-13

    open access unreviewed
  2. 2
  3. 3
  4. 4
    Metabolomic biomarkers and metabolic remodelling in genetically characterised hypertrophic cardiomyopathy: a systematic review.

    Ahmad Razmy AH, Abd Latip N, Ab-Rahim S, Sheikh Abdul Kadir SH. · 2026-10-03

    open access unreviewed
  5. 5
  6. 6
    Role of the Gut-Liver-Kidney Axis in Disease Manifestation and Biomarker Alterations.

    Mashima R, Ishige N. · 2026-09-15

    open access unreviewed
  7. 7
    Ribosome-inactivating proteins in bacteria.

    El-Ramly MH, Fowler CC. · 2026-09-01

    open access unreviewed
  8. 8
    Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine.

    Biddeci G, Spinelli G, Colomba P, Anania M, Duro G, Di Blasi F. · 2026-09-04

    open access unreviewed
  9. 9
    Generation of the functionally enhanced proximal tubular cells from human iPSC-derived kidney organoids.

    Kim S, Nam SA, Kim JW, Yi J, Woo JJ, Lee M, Lee J, Kim TH, Kim H, Kim HW, Park J, Kim YK. · 2026-09-03

    open access unreviewed
  10. 10
    Systematic Analysis of Plasma-Derived Extracellular Vesicle-Enriched Samples in Age-Related Macular Degeneration Reveals Oxidative Stress Linked to Altered Lipid and Protein Profiles.

    Kurzawa-Akanbi M, Haggarty J, Hansohn C, Patel MT, Cree AJ, Teo P, Armstrong M, Coles N, Platt M, Griffiths H… · 2026-08-29

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.